People with metabolic syndrome are twice more likely to develop cerebrovascular disease (CVD) and over five times more likely to develop type 2 diabetes compared to people without metabolic syndrome.
Experts at the University of Bradford's Institute of Cancer Therapeutics are developing what's been dubbed a cancer 'smart bomb' from the autumn crocus, a flower native to Britain.
Yale scientists have suggested that a battle that brews in the mother's womb between the father's biological goal to produce the biggest, healthiest baby possible against the mother's need to live through delivery might help explain preeclampsia, an often deadly disease of pregnancy.
A high-level meeting chaired by the Prime Minister, Dr Manmohan Singh, in New Delhi on Monday evening decided to allow Foreign Direct Investment (FDI) without any limits(100%) under the automatic route for greenfield investments in the pharma sector. This will facilitate addition of manufacturing capacities, technology acquisition and development, a Press Information Bureau Press release said.
The Mumbai-based Taj Pharmaceuticals has received tentative approval from US FDA to manufacture and sell Drug Oxycodone Tablets 5 to 30 mg in the UK and European markets. Oxycodone is a strong narcotic pain-reliever and cough suppressant similar to morphine, codeine, and hydrocodone.
A rarest of rare heart surgery was performed by Dr R Ravi Kumar, Director, Institute of Cardio Vascular Disease at Chettinad Health City and his team on a 65 yr old Iraqi patient in Chennai.
The government has decided to continue 100% Foreign Direct Investment (FDI) in Greenfield pharma sector while for the Brownfield investments, FDI will be allowed subject to Foreign Investment Promotion Board (FIPB)’s approval.
The Illinois(US)-based Akorn Inc., a niche generic pharmaceutical company, has entered into an agreement to acquire certain assets of Kilitch Drugs (India) Limited (KDIL), a leading contract manufacturer of sterile injectable in India, as well as certain assets of NBZ Pharma Limited, for approximately $52 million in cash and future contingent payments totaling up to approximately $6 million based on the achievement of certain milestones and financial targets.
Global pharma major Sanofi Aventis, which acquired the Hyderbad-based Shantha Biotechnics in 2009, is investing Rs 500 crore to set up one of its largest vaccine manufacturing facilities near Hyderabad.
Boehringer Ingelheim India and Eli Lilly India (Lilly) have announced that they are entering into an agreement specific to India to co-promote a portfolio of diabetes compounds currently either in late-stage development or on the market.
Despite having one of the fastest growing economies in the world, India continues to lag in terms of both antibiotic access and controlling antibiotic resistance, according to the 1st Global Forum on Bacterial Infections: Balancing Treatment Access and Antibiotic Resistance that was held in the capital during October 3-5, 2011.
The Hyderabad-based Suven Life Sciences Ltd (SUVEN) has bagged Pharmexcil’s “Patent Award” for securing the most number of product patents during 2010/11 for their New Chemical Entities (NCE’s) under Gold Category, third year in a row. The Awards were presented during the "Awards Function for Exports and patents during India-LAC Pharma Business Meet” organized by Pharmexcil and by Department of Commerce, Government of India.
Netscribes (India) Pvt. Ltd., a knowledge consulting solutions company, has launched a report on the ` Cardiovascular Pharmaceuticals Market in India 2011’ .
Three men whose work helped uncover how the immune system works, and in so doing identified three milestones in an evolutionary path extending two billion years into the past, were awarded the Nobel Prize in Physiology or Medicine for 2011
Strides Arcolab Limited (Strides) has received US FDA approval for Clindamycin Injection, USP an antibiotic used to treat bacterial infections. It will be available in three single-dose vial sizes and in pharmacy bulk packaging. As with all products in Strides – Sagent JV, Clindamycin features the Prevent IV, a company press release said in Bangalore.
